SH

Sarah J. Hatsell

RP Regeneron Pharmaceuticals: 10 patents #119 of 810Top 15%
📍 Nyack, NY: #11 of 109 inventorsTop 15%
🗺 New York: #14,659 of 115,490 inventorsTop 15%
Overall (All Time): #488,984 of 4,157,543Top 15%
10
Patents All Time

Issued Patents All Time

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
12089576 Nucleic acids comprising a modified rodent activin a receptor type 1 (Acvr1) gene Aris N. Economides, Christopher Schoenherr, Vincent J. Idone 2024-09-17
11945872 Anti-ACVR1 antibodies and uses thereof Vincent J. Idone, Aris N. Economides 2024-04-02
11419319 Genetically modified rodent with an inducible ACVR1 mutation in exon 7 that causes ectopic bone formation Aris N. Economides, Christopher Schoenherr, Vincent J. Idone 2022-08-23
11407822 Treatment of fibrodysplasia ossificans progressiva Aris N. Economides, Vincent J. Idone 2022-08-09
RE49121 Genetically modified mouse with an inducible ACVR1 gene with a mutant R206H exon 5 that has ectopic bone formation Aris N. Economides 2022-07-05
10531648 Conditional rodent Acvr1 mutant gene Aris N. Economides 2020-01-14
10470444 Method for making a genetically modified mouse with an inducible ACVR1 mutation that causes ectopic bone formation Aris N. Economides 2019-11-12
10448621 Rodent embryonic stem cell with conditional ACVR1 mutant alleles Aris N. Economides 2019-10-22
9999207 Nucleic acid construct for making a genetically modified rodent with an inducible ACVR1 mutation that causes ectopic bone formation Aris N. Economides 2018-06-19
9510569 Genetically modified mouse with an inducible Acvr1 gene with a mutant R206H exon 5 that has ectopic bone formation Aris N. Economides 2016-12-06